Literature DB >> 10962330

Endourologic treatment of nephrocalcinosis.

K Kerbl1, R V Clayman.   

Abstract

Calcifications of the kidney may be located free within the collecting system, attached to a papilla, trapped beneath the urothelium, or sequestered in the renal parenchyma. Extracorporeal shock wave lithotripsy has failed to render patients who presented with nephrocalcinosis stone free because of the submucosal location of some of the calculi. We report a unique case of symptomatic nephrocalcinosis in which the patient was rendered stone free using flexible ureteroscopy and intrarenal laser and electrohydraulic lithotripsy to treat both the attached and submucosal papillary calculi.

Entities:  

Mesh:

Year:  2000        PMID: 10962330     DOI: 10.1016/s0090-4295(00)00675-0

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

Review 1.  Recent advances in the identification and management of inherited hyperoxalurias.

Authors:  David J Sas; Peter C Harris; Dawn S Milliner
Journal:  Urolithiasis       Date:  2018-12-10       Impact factor: 3.436

2.  Nephrocalcinosis: re-defined in the era of endourology.

Authors:  Nicole L Miller; Mitchell R Humphreys; Fredric L Coe; Andrew P Evan; Sharon B Bledsoe; Shelly E Handa; James E Lingeman
Journal:  Urol Res       Date:  2010-11-06

Review 3.  Primary and secondary hyperoxaluria: Understanding the enigma.

Authors:  Bhavna Bhasin; Hatice Melda Ürekli; Mohamed G Atta
Journal:  World J Nephrol       Date:  2015-05-06

4.  Surgical management of stone disease in patients with primary hyperoxaluria.

Authors:  Alonso Carrasco; Candace F Granberg; Matthew T Gettman; Dawn S Milliner; Amy E Krambeck
Journal:  Urology       Date:  2015-03       Impact factor: 2.649

5.  Extracorporal shock wave lithotripsy in the management of stones in children with oxalosis--still the first choice?

Authors:  Eslam Al-Abadi; Sally-Anne Hulton
Journal:  Pediatr Nephrol       Date:  2013-02-09       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.